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cedure in anamnesis, 3 pts had initial changes on ECG. In 1 case we
had alcohol leakage from septal branch to LAD – aspiration, absence of
MACE. Also we had 1 case of ventricular ﬁbrillation on the 10-th day
after procedure. Mean interventricular wall thickness decreased from
2,5  0,3cm to 1,9  0,1cm. MR decreased from at least moderate to
mild or complete disappearance. NYHA class reduced from 2,9 to 1,1.
CONCLUSIONS ASA is effective and safe method of HOCM treatment.
The reduction of the duration of the procedure, decreasing of the number
of the complications and general improvement of the results of interven-
tional HOCM treatment are possible with accumulation of the experience.
CATEGORIES STRUCTURAL: Alcohol Septal Ablation/HOCM
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BACKGROUND Septal myectomy is the gold standard for medically-
refractory patients with hypertrophic obstructive cardiomyopathy
(HCM). There is a subset of patients who have severe exertional
symptoms without a resting or provocable left ventricular outﬂow
tract (LVOT) gradient on noninvasive testing. These patients may
demonstrate obstruction on hemodynamic catheterization with
isoproterenol challenge but is has remained unclear how they respond
to septal reduction therapy. We aimed to assess the ability of
isoproterenol challenge to predict symptom resolution with myec-
tomy in a selected HCM population.
METHODS 18 symptomatic HCM patients (NYHA class III or IV) with
labile obstruction on isoproterenol challenge underwent surgical
myectomy between February 2003 and April 2009. Patients were
reassessed for symptom resolution after a median of 4 (IQR 3-7) years.
RESULTS Post-myectomy, 13 patients (72.2%) had complete symptom
resolution, while 5 (27.8%) had improved but persistent symptoms. Pa-
tients with complete symptom resolution had a greater increase in left
atrial pressure (LAP) and tau with isoproterenol [3 (IQR -2-8) mmHg vs. -5
(IQR -8.5–1) mmHg; p¼0.01] and [-0.7 (IQR -13-22) ms vs. -44 (IQR -48–0.2)
ms; p¼0.03] (Figure 1). The mean change in LVOT gradient with peak
isoproterenol was signiﬁcantly greater among patients with complete
symptom resolution compared to patients with improved but persistent
symptoms [(104 (IQR 66-123) mmHg vs. 55 (IQR 38-74) mmHg; p¼0.01).
All patients with increase in LAP with isoproterenol and LVOT gradient
>100 mmHg achieved complete symptom resolution.CONCLUSIONS Patients with residual symptoms post-myectomy had
less increase in LAP and tau with isoproterenol indicating a “ﬁxed”
component to diastolic ﬁlling, as opposed to patients with symptom
resolution whose response was indicative of elevation in ﬁlling pres-
sures secondary to dynamic obstruction.
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BACKGROUND Current practice guidelines suggest that ASA may be
the treatment of choice for elderly patients with medically refractory
symptomatic HOCM because of the risks associated with cardiac sur-
gery in this patient population. We sought to determine the outcomes
and complications in elderly patients who undergo ASA.
METHODS 220 alcohol septal ablations were performed on 198 pa-
tients age 65 years or older (age 73 5y, 68% F) over a 15 year period.
Subgroup analyses were performed for patients 75 years of age
(n¼73, 80% F) and for patients age 65-74 (n¼125, 61% F).
RESULTS Of 220 ASA procedures performed, the primary endpoint of
in-hospital death occurred in four patients (1.8%). Among patients 
75 years of age (79 procedures) three patients died (4%) compared to
one death (0.7%) among patients age 65-74 years of age (141 ASA
procedures). 26 (11.8%) were repeat ablations. Complete heart block
(CHB) requiring permanent pacemaker occurred in 21 patients (9.5%).
For patients age  75 years the rate CHB requiring pacemaker im-
plantation was 11.3%. Bleeding or access site complications were re-
ported in eight patients (4.1%) among the entire cohort. Bleeding or
access site complications occurred in ﬁve patients (3.5%) who were 
75 years of age at the time of procedure.
CONCLUSIONS This study shows the safety of ASA in elderly patients.
Compared to the entire cohort of patients all ages undergoing ASA, the
elderly did not have a statistically signiﬁcant difference in complete
heart block requiring pacemaker implantation, bleeding/access site
complications, or procedural mortality. Although mortality rate of the
elderly cohort was not increased over historic controls, patients >75
years of age had statistically signiﬁcant higher mortality than patients
65-74 years of age.65-75y >75y Total P-ValueNumber of patients
(procedures)125 (141) 73 (79) 198 (220) -Deaths: number (%) 1 (0.7%) 3(4%) 4(1.8%) 0.0002CHB: number(%) 12 (5.4%) 9 (11.3%) 21 (9.5%) 0.39Bleeding/access
complication4 (5.0%) 5 (3.5%) 9(4.1%) 0.21CATEGORIES STRUCTURAL: Alcohol Septal Ablation/HOCM
KEYWORDS Ablation, alcohol septal, Hypertrophic cardiomyopathy
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BACKGROUND Alcohol septal ablation (ASA) is an established treat-
ment for symptomatic hypertrophic obstructive cardiomyopathy
(HOCM). The impact of race and gender on the results of ASA in pa-
tients with HOCM has not been reported in the literature.
METHODS Six hundred and forty-ﬁve patients with symptomatic HOCM
despite optimal medical therapy underwent ASA at a single center over a
ﬁfteen-year timeperiod (1999 to 2014). All patientswere grouped according
B306 J O U R N A L O F T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y , V O L . 6 6 , N O . 1 5 , S U P P L B , 2 0 1 5toself-identiﬁedrace (CaucasianorAfricanAmerican)andgender.Datawas
retrospectivelygatheredandprospectively analyzed forprocedural success
(reduction in LVOT gradient) and procedural complications.
RESULTS There were 298 males (5313y) and 347 females (6015.5y).
The male cohort received a higher dose of alcohol; however, there
were no other differences in procedural success, mortality, or need for
permanent pacemaker implantation. (Table 1) There were 555
Caucasian (5715y) and 59 African American (5915y) patients in the
study. African American patients had more septal arteries injected
with more alcohol, a higher post ablation creatinine kinase level,
and a greater reduction in peak LVOT gradient compared to the
Caucasian cohort. There was no difference in procedural mortality
or the need for permanent pacemaker. (Table 2)Male (STD; CI; or
number of
incident)Female (STD; CI;
or number of
incident)P value for
genderCaucasian (STD;
CI; or number of
incident)African American
(STD; CI; or
number of
incident) P value for raceN 298 347 NA 555 59 NAAge 53 (14; þ/- 1.5) 60 (15.5; þ/- 1.6) 0.0000000056 57 (15; þ/- 1.25) 59 (14; þ/- 4) 0.3Reduction in
Gradient87 (51; þ/- 6.14) 84 (54.8; þ/- 6.1) 0.85 84 (50; þ/- 4.5) 99 (55; þ/- 16) 0.05Number of
Septal
Arteries
Injected1.16 (0.4; þ/-
0.05)1.16 (0.45; þ/-
0.05)0.96 1.15 (0.4; þ/-
0.03)1.26 (0.5; þ/-
0.13)0.05Amount of
EtHO
Injected2.27 (0.7; þ/-
0.08)2.14 (0.76; þ/-
0.08)0.03 2.2 (0.74; þ/-
0.06)2.34 (0.7; þ/-
0.2)0.09Peak Creatinine
Kinase1194 (701; þ/- 81) 1082 (790; þ/-
85)0.06 1099 (765; þ/-
65)1426 (646; þ/-
170)0.001Rate of Heart
Block
Requiring
PPM6 % (18 of 298) 6.9% (24 of 347) 0.65 6.3 % (35 of 555) 8.5% (5 of 59) 0.52Procedural
Death1% (2 of 298) 1.2 % (4 of 347) 0.52 0.9% (5 of 555) 1.7 % (1 of 59) 0.55CONCLUSIONS There was no signiﬁcant effect of gender on the out-
comes of alcohol septal ablation. Despite the need for more septals
injected and ahigher alcohol dose (larger infarct size) inAfricanAmerican
patients, the clinical outcomes were similar to the Caucasian cohort. The
higher alcohol dose and infarct size likely reﬂects the greater septal hy-
pertrophy typically seen in African American patients with HOCM.
CATEGORIES STRUCTURAL: Alcohol Septal Ablation/HOCM
KEYWORDS Ablation, alcohol septal, Hypertrophic obstructive car-
diomyopathy, Racial disparities
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Endovascular Therapy Versus Medical Therapy for Management of Acute
Ischemic Stroke: Systematic Review and Meta-Analysis of Prospective
Randomized Controlled Trials
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New Orleans, USABACKGROUND Several randomized controlled trials (RCTs) have
shown inconsistent results in regards to outcomes in patients with
acute ischemic stroke (AIS) undergoing endovascular therapy (ET)
versus standard medical treatment (MT). Thus we sought to evaluate
the effectiveness and safety of ET compared to MT in patients with
AIS utilizing data from all available RCTs.
METHODS We conducted electronic searches of RCT. The primary
efﬁcacy endpoints were modiﬁed Rankin scale 0 to 2, recurrent stroke,
and all-cause mortality. Safety endpoints included intracranial hem-
orrhage (ICH) and all-bleeding events. Odds ratios (OR) and 95%
conﬁdence intervals (CI) computed using the Mantel-Haenszel
method. Random-effect model was used. Sensitivity analysis and bias
quantiﬁcation were also assessed.
RESULTS Ten RCTs were included, with a total of 2,716 patients. There
was a signiﬁcant difference favoring ET compared to MT for modiﬁed
Rankin scale score 0 to 2 (OR: 0.62; 95% CI: 0.44 to 0.86; p< 0.01). We
found no difference between ET vs. MT for all-cause mortality (OR:
0.92; 95% CI: 0.74 to 1.14; p¼ 0.42) and recurrent stroke (OR: 1.82; 95%
CI: 0.79 to 4.16; p¼ 0.16). For safety outcomes, there was an increased
risk of all-bleeding events (OR: 1.91; 95% CI: 1.22 to 3.00; p< 0.01) and
ICH (OR: 1.95; 95% CI: 1.24 to 3.06; p< 0.01) following ET. Sensitivity
analysis of one study removal showed that exclusion of the PROACT II
study from the analysis for all-bleeding and ICH outcomes changed the
ﬁnal effect to a non-signiﬁcant difference between both approaches.
No evidence of publication bias was observed. The number needed to
treat for a Rankin score 0 to 2 is 8; the number needed to harm for all-
bleeding and ICH is 8 and 10 respectively.
CONCLUSIONS The results of this meta-analysis indicate that in pa-
tients with AIS, ET is superior to standard MT for disability-free sur-
vival, with an increased risk of bleeding and ICH.
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BACKGROUND We retrospectively analyzed data from our center to
quantify complication rates in patients undergoing carotid artery stent-
ing (CAS). Thereby, we sought to evaluate a possible association between
the vessel (left vs. right) treated and the respective complication rate.
METHODS In a retrospective analysis of 1124 consecutive patients
(pts) undergoing CAS at our institution between December 1997 and
January 2015, 557 pts (49,6%) underwent stenting of the left carotid
artery (group 1) and 567 pts (50,4%) of the right carotid artery (group
2). Thirteen patients with a simultaneous intervention of both carotid
arteries were excluded from our analysis. The baseline data of both
groups were similar (mean age 71.4  38.9 years, 175 females (31.4%)
in group 1 versus mean age of 71.9  39.1 years and 189 females (33.3%)
in group 2; no differences in comorbidities).
RESULTS CAS was successful in all but 32 patients (13 [2.3%] of them in
group 1, and 19 [3.6%] in group 2, p¼ns). The mean degree of stenosis
was reduced from 85.5 10.3% to 3.1 6.4% in group 1, and 85.9 9.6%
to 3.5 7.3% in group 2, respectively (p¼ns). Themean stent lengthwas
27.9  6.7 mm in group 1 and 27.5  9.8 mm in group 2 (p¼ns), and the
mean procedure timewas not different between both groups (17.2 11.4
